Insulin Savings for Patients Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 21, 2022
Referred to the Subcommittee on Health.
Feb 18, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 18, 2022
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Insulin Savings for Patients Act
This bill requires 100% of negotiated price concessions for covered insulin products under the Medicare prescription drug benefit to be reflected at the point of sale by 2024. The Government Accountability Office must annually report on the effects of the bill's implementation, including with respect to insulin prices.
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
3
Cite this page
U.S. Congress. (2026). H.R. 6757: Insulin Savings for Patients Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6757/
"H.R. 6757: Insulin Savings for Patients Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6757/.
H.R. 6757, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6757/.
[H.R. 6757: Insulin Savings for Patients Act](https://openamerica.io/bill/117-HR-6757/)